Skip to main content

Cynthia Miller, MD, MPH, FACP

Pharma Insights
10/20/2021
Cynthia Miller, MD, MPH, FACP, discusses initiatives pharmaceutical companies can employ to assist physician groups and payers in adding appropriate pharmacologic therapies to reduce the burden of COVID-19 on persons with diabetes.
Cynthia Miller, MD, MPH, FACP, discusses initiatives pharmaceutical companies can employ to assist physician groups and payers in adding appropriate pharmacologic therapies to reduce the burden of COVID-19 on persons with diabetes.
Cynthia Miller, MD, MPH, FACP,...
10/20/2021
Journal of Clinical Pathways
Pharma Insights
03/16/2022
Elizabeth Oyekan, PharmD, FCSHP, CPHQ, and colleagues propose a vision for the future of the patient/consumer experience to serve as a blueprint for organizations to develop and implement a strategy that is both effective and in alignment...
Elizabeth Oyekan, PharmD, FCSHP, CPHQ, and colleagues propose a vision for the future of the patient/consumer experience to serve as a blueprint for organizations to develop and implement a strategy that is both effective and in alignment...
Elizabeth Oyekan, PharmD, FCSHP,...
03/16/2022
Journal of Clinical Pathways
Pharma Insights
02/15/2022
Elizabeth Oyekan, PharmD, FCSHP, CPHQ, and colleagues address health care disparities in patients with chronic conditions, the roles of health systems and payers in closing these gaps, and a customizable SDOH toolbox to help stakeholders...
Elizabeth Oyekan, PharmD, FCSHP, CPHQ, and colleagues address health care disparities in patients with chronic conditions, the roles of health systems and payers in closing these gaps, and a customizable SDOH toolbox to help stakeholders...
Elizabeth Oyekan, PharmD, FCSHP,...
02/15/2022
Journal of Clinical Pathways